SYK · News · 20261103N
Acquisition / Partnership / Divestiture
STRYKER CORP · 2026-11-03 · Importance 58 · Surprise 42 · In source text
Stryker is investing approximately US$400 million in UK surgical robotics developer CMR Surgical. The agreement gives Stryker an exclusive option to acquire CMR Surgical’s remaining equity and exclusive US commercial agency rights for its Versius surgical robotics portfolio. CMR will retain responsibility for product development and commercialization outside the US, while Stryker plans to use its commercial reach to expand US sales.
Key facts
- Stryker is investing approximately US$400 million in CMR Surgical and has an exclusive option to acquire the remaining equity. source
- Stryker secured exclusive US commercial agency rights for CMR Surgical's Versius surgical robotics portfolio. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | -0.7% | Stryker is investing approximately US$400 million in CMR Surgical and has an exclusive option to acquire the remaining equity. |
| revenue | positive | contingent | — | Stryker secured exclusive US commercial agency rights for CMR Surgical's Versius surgical robotics portfolio. |